FOLH1 and metastatic neoplasm: PSMA is membrane zinc metalloprotease, also known as glutamate carboxypeptidase II (GCPII), which is mainly expressed in normal human prostate epithelium and is enormously increased up to thousand-fold in PCa, including metastatic disease [10,12].